A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer (Q36697575)
Jump to navigation
Jump to search
scientific article published on 2 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer |
scientific article published on 2 October 2013 |
Statements
1 reference
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer (English)
1 reference
Rakesh K Jain
1 reference
Marek Ancukiewicz
1 reference
Andrew X Zhu
1 reference
Richard S Finn
1 reference
Mary Mulcahy
1 reference
Jayne Gurtler
1 reference
Weijing Sun
1 reference
Jonathan D Schwartz
1 reference
Rita P Dalal
1 reference
Adarsh Joshi
1 reference
Rebecca R Hozak
1 reference
Yihuan Xu
1 reference
Francis W Nugent
1 reference
Dan G Duda
1 reference
Keith Stuart
1 reference
2 October 2013
1 reference
1 reference
6614-6623
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference